Objectives-To study the in vitro adhesion of polymorphonuclear leucocytes (PMNLs) to endothelial cells in patients with Behcet's disease (BD), and the humoral and cellular factors which may contribute to adhesion. Methods-A total of 118 patients with BD and 60 healthy controls were studied. In vitro adhesion of chromium-51 labelled normal neutrophils to human umbilical vascular endothelial cell (HUVEC) monolayers were studied in the presence of normal serum or serum obtained from patients with BD. Adhesion of neutrophils from patients with BD to HUVEC stimulated with tumour necrosis factor (TNF), interleukin-1 (IL-1), and lipopolysaccharide (LPS) and adhesion molecule (CD11a, CDl1b, CD18 and L-selectin) expression on the patient's neutrophils and lymphocytes were determined, and the serum concentration of IL-8 was measured. Results-Sera from patients with BD were found to enhance the adherence of normal PMNLs to HUVEC monolayers in vitro.
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Adherence was determined as the percentage of the total radioactivity added to the wells (adherence ratio).
All patient and control sera were tested in triplicate. To obtain a background count, three wells were processed as the same way but without addition of PMN.
NEUTROPHIL ADHESION TO STIMULATED HUVECs
Confluent HUVECs in 96 well plates were washed twice with prewarmed (37°C) RPMI medium without ECGF and heparin, then 100 pl of RPMI containing lipopolysaccharide (LPS) 1 ,ug/ml (Sigma Chemical, USA), TNFct 10 ng/ml (Seralab, UK), or 10 U/ml of IL-I (Seralab) was added for stimulation. Plates were incubated at 37°C for four hours and washed gently with PBS. Neutrophils obtained from five patients and five healthy controls were pooled separately, labelled with chromium-51, and the neutrophil adhesion assay performed as described above using stimulated HUVECs, or unstimulated HUVECs as control. All pooled sera were tested in 12 wells and results were expressed as the mean of the 12 wells.
BLOCKING OF ADHESION BY MONOCLONAL ANTIBODIES
HUVECs and normal pooled PMNLs obtained from five individuals were pretreated with monoclonal antibodies (MAb) for 15 minutes, following which the adhesion assay described above was performed in the presence of MAb. However, in contrast to the above experiments, five patient sera having a high adhesion capacity (at least one SD above the mean capacity of the patient group) were pooled and used in the adhesion assay. HUVECs were incubated with anti-E-selectin (clone ENA-2, F(ab)2 fragment, Monosan, The Netherlands) and anti-intercellular adhesion molecule-i (anti-ICAM-1) ( or PBS alone for 90 minutes at 37°C. Cells were then washed twice with the wash buffer, stained by monoclonal antibodies as described above and analysed by using FACScan. Mean fluorescence intensities were also estimated, in order to measure the overall effect of patient serum on PMNLs.
The effect of patient serum on HUVEC surface adhesion molecules was also determined. Five patient sera with high adhesion capacity (at least one SD above the mean capacity of the patient group) were selected. Stimulation of HUVECs by LPS, TNFt, and IL-la caused increased adhesion of both normal and patient neutrophils. As expected, this effect was more pronounced for patient neutrophils (table 2) .
EXPRESSION OF SURFACE ADHESION MOLECULES
The number of PMNLs expressing CD1la was significantly increased in patients (89-4 (10-8)% (n =50)) compared with controls (71-0 (8-9)% (n = 19)). The proportion of cells expressing CD 1 1 b, CD 18, and L-selectin was greater than 90% in both patients' and control PMNLs. Adhesion molecule expression on the Values are mean (SD). IL-la = Interleukin-la 10 U/ml; TNFa = tumour necrosis factor a 10 ng/ml; LPS = lipopolysaccharide 1 pg/ml. *Mann-Whitney U test. Figure 2 shows the expression of ICAM-1 on the endothelial cells after incubation with patient sera. Relative mean fluorescence intensity of the ICAM-1 (CD54) expression on endothelial cells was not significantly increased after treatment with patient sera, but the number of endothelial cells expressing ICAM-1 was slightly increased (greater peak value) after incubation ( fig 2) . Expression of E-selectin, however, did not change after incubation with patient sera.
INHIBITION OF ADHESION BY MAb
All monoclonal antibodies against cell adhesion molecules tested in this study caused significant inhibition of normal neutrophil adhesion to HUVECs in the presence of patients' sera (table 4) . This inhibition was greater with antiCD1la and anti-CD18 treatment (37 5% and 37-6%, respectively) than that observed 1 ahin, Akoglu, Direskeneli, $en, Lawrence using CD1 lb. Combination of these monoclonals produced synergistic effects and even greater inhibition. Anti-CD19 (a monoclonal antibody unrelated to adhesion molecules) was used as a control in the adhesion assay: no inhibition of adhesion was demonstrated (table 4) .
SERUM CONCENTRATIONS OF IL-8
Mean serum concentrations of IL-8 were significantly increased in sera from patients with Behcet's disease compared with sera from normal controls (490 (470) pg/ml v 97-5 (56 3) pg/ml; p = 0 001). Fourteen sera from patients expressed greatly increased IL-8 levels (at least 2 SD greater than the mean). Eleven of these sera were also found to promote greatly increased adhesion ratio (adhesion ratio at least 2 SD greater than the mean As observed in all experimental systems using cell culture, day to day differences between experiments was significant and standard deviations were high. However, as an increase in adhesion ratio was a consistent finding in all our experiments (table 1), we suggest that the increased adhesion found with sera from patients with Behcet's disease reflects the actual situation in this disorder.
The increased neutrophil adhesion in patients with Beh,et's disease that we observed, and the significant increase of adhesion after stimulation of HUVECs by IL-lot, TNFoL, and LPS (table 2) , may reflect functional or quantitative upregulation of surface adhesion molecules on PMNLs in Beh,et's disease. Indeed, the expression of some adhesion molecules on PMNLs obtained from patients with Beh,et's disease was found to be quantitatively increased.
The number of neutrophils expressing lymphocyte function associated antigen 1 (LFA-1) (CD 1 1 a/CD 18) molecules was increased in patients with Beh,et's disease. Incubation of normal neutrophils with patients' sera induced a significant increase in CD 11 a and CD 18 molecules (table 3) , and MAbs against these molecules caused significant inhibition of adhesion compared with that observed in the presence of other MAbs. These findings indicate that the LFA-1 molecule, which is composed of CD1 la and CD 18, has a significant role in the increased adhesion of neutrophils from patients with Beh,et's disease, and that E-selectin is not involved in the process. As inhibition of adhesion with different combinations of MAbs was not complete, the role of other adhesion molecules such as P-selectins should also be considered.
Interestingly, sera of patients with Beh,et's disease caused a significant increase of in vitro adhesion and induced greater expression of adhesion molecule on normal PMNLs, which may indicate that an unknown serum factor(s) is responsible for all these abnormalities, as suggested previously by Jorizzo et al. 8 A number of serum factors may be involved in the adhesion of PMNLs to endothelial cells: for example IL-1, IL-2, TNF, granulocyte macrophage colony stimulating factor, IL-6, platelet activating factor. Increased concentrations of IL-i, and PMNLs mediated injury, through an adhesion inhibitory effect. 22 The significance of the increased IL-8 concentrations present in the sera of patients with Behqet's disease remains open to speculation. Although we do not know the underlying mechanism for the increased plasma IL-8 in these patients, it may, together with IL-1, IL6, and TNF, be responsible for the increased adhesiveness of PMNLs found in this study. Alternatively, the increased IL-8 in the sera of our patients may have been a secondary phenomenon, the main function being protection of vessel walls from PMNL mediated injury, as suggested by Gimbrone.
We believe that these abnormalities reflect the inflammatory nature of Behqet's lesions, though these in vitro studies are far from representing the actual situation in the inflammatory microenvironment in the disease. Further studies of the other adhesion molecules and a more specific understanding of the interactions of different mediators and cell surface molecules will clarify the situation in patients with Behqet's disease. We are grateful to Prof H Yazici and his colleagues from Cerrahpasa Medical School, Istanbul, for allowing us to collect blood samples from their patients. We also thank Dr N Hekim for performing the von Wilebrand factor assay of our endothelial cell culture supernatants.
